Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Journal of Kidney Cancer and VHL
|
February 23, 2018
Nivolumab in Renal Cell Carcinoma: Current Trends and Future Perspectives
Cesar E Ochoa, Richard W Joseph
Melanoma Research
|
January 8, 2019
Inositol hexaphosphate plus inositol induced complete remission in stage IV melanoma: a case report
Sharad Khurana, Candice Baldeo, Richard W Joseph
Urologic Oncology
|
March 6, 2017
Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice
Richard W Joseph, Gurkamal Chatta, Ulka Vaishampayan
BMC Medicine
|
March 6, 2012
Therapy for metastatic melanoma: the past, present, and future
Laura Finn, Svetomir N Markovic, Richard W Joseph
Molecular Immunology
|
March 10, 2015
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
Abhisek Swaika, William A Hammond, Richard W Joseph
Drug Design, Development and Therapy
|
June 27, 2014
Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma
Abhisek Swaika, Jennifer A Crozier, Richard W Joseph
Expert Opinion on Drug Discovery
|
July 26, 2016
Patient-derived tumor xenograft models for melanoma drug discovery
Antoneicka L Harris, Richard W Joseph, John A Copland
The Journal of Supportive Oncology
|
January 20, 2009
Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care
Richard W Joseph, Daniel R Couriel, Krishna V Komanduri
Clinical Advances in Hematology & Oncology : H&O
|
June 8, 2017
Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities
Gabriel G Malouf, Richard W Joseph, Amishi Y Shah, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
April 7, 2018
New-onset insulin-dependent diabetes due to nivolumab
Ali A Zaied, Halis K Akturk, Richard W Joseph, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Journal of Kidney Cancer and VHL
|
February 23, 2018
Nivolumab in Renal Cell Carcinoma: Current Trends and Future Perspectives
Cesar E Ochoa, Richard W Joseph
Melanoma Research
|
January 8, 2019
Inositol hexaphosphate plus inositol induced complete remission in stage IV melanoma: a case report
Sharad Khurana, Candice Baldeo, Richard W Joseph
Urologic Oncology
|
March 6, 2017
Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice
Richard W Joseph, Gurkamal Chatta, Ulka Vaishampayan
BMC Medicine
|
March 6, 2012
Therapy for metastatic melanoma: the past, present, and future
Laura Finn, Svetomir N Markovic, Richard W Joseph
Molecular Immunology
|
March 10, 2015
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
Abhisek Swaika, William A Hammond, Richard W Joseph
Drug Design, Development and Therapy
|
June 27, 2014
Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma
Abhisek Swaika, Jennifer A Crozier, Richard W Joseph
Expert Opinion on Drug Discovery
|
July 26, 2016
Patient-derived tumor xenograft models for melanoma drug discovery
Antoneicka L Harris, Richard W Joseph, John A Copland
The Journal of Supportive Oncology
|
January 20, 2009
Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care
Richard W Joseph, Daniel R Couriel, Krishna V Komanduri
Clinical Advances in Hematology & Oncology : H&O
|
June 8, 2017
Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities
Gabriel G Malouf, Richard W Joseph, Amishi Y Shah, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
April 7, 2018
New-onset insulin-dependent diabetes due to nivolumab
Ali A Zaied, Halis K Akturk, Richard W Joseph, et al.
Page
of 9